MedTrace Logo

Treatment of Post-covid Syndrome in Patients Treated in Intensive Care

NCT05119608 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-01-13

No results posted yet for this study

Summary

The present study is a pilot randomized controlled trial, which identifies and diagnoses mental health problems in survivors of critical COVID-19 infection at 12 months post-ICU care, and randomize patients to either an ACT-enforced CBT intervention, or to treatment as usual.

Conditions

Interventions

BEHAVIORAL

CBT/ACT

10-session ACT-re-enforced CBT intervention.

Sponsors & Collaborators

  • Region Stockholm

    collaborator OTHER_GOV

  • Lund University

    collaborator OTHER

  • Karolinska Institutet

    collaborator OTHER

  • Region Skane

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-09-30
Completion
2025-11-15

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05119608 on ClinicalTrials.gov